Good News Inspiration Inspiration JLS Foundation Living Life as a Contribution

Seattle Children’s Set to Launch First U.S. CAR T-Cell Clinical Trial for Children with Lupus

The John L. Scott Foundation helps support Seattle Children’s

Seattle Children’s | Casey Egan

Seattle Children’s has received FDA authorization to launch the first chimeric antigen receptor (CAR) T-cell clinical trial in the U.S. for children under 18 with the most common form of lupus.

Systemic lupus erythematosus is a chronic autoimmune disorder that affects multiple organ systems, resulting in significant morbidity and mortality. Approximately 20% of lupus patients have disease onset during childhood, and children with lupus are at particular risk for severe disease and worse long-term outcomes.

Read the full article: Seattle Children’s Set to Launch First U.S. CAR T-Cell Clinical Trial for Children with Lupus

Related posts

John L. Scott Puyallup Main and Puyallup South Hill offices hold Summer Send-Off event

jlspr

Swanepoel Names Lennox Scott Among The Most Powerful People In Real Estate.

jlspr

John L. Scott Mercer Island donates dinner to Mercer Island firehouse staff

jlspr